$76.69
-0.35[-0.45%]
At close: May 17
$76.69
0[0.00%]
PreMarket: 4:59AM EDT
AstraZeneca
(NASDAQ:AZN)AstraZeneca Stock (NASDAQ:AZN), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/12/2021 | AZN | AstraZeneca | FY | 2021 | $2.52 | $2.70 | $3.27 | — | — | — | Get Alert |
| 07/29/2021 | AZN | AstraZeneca | FY | 2021 | $2.52 | $2.70 | $3.33 | — | — | — | Get Alert |
| 04/30/2021 | AZN | AstraZeneca | FY | 2021 | $2.38 | $2.50 | $2.11 | — | — | — | Get Alert |
| 02/11/2021 | AZN | AstraZeneca | FY | 2021 | $2.38 | $2.50 | $2.95 | — | — | — | Get Alert |
| 10/24/2019 | AZN | AstraZeneca | FY | 2019 | $3.50 | $3.70 | $1.78 | — | — | — | Get Alert |
FAQ
What is the most recent guidance for AstraZeneca (AZN)?
The last reported Earnings numbers were from November 12, 2021 for the full year 2021 and was for an earnings per share guidance in the range of $2.53 and $2.70 versus the estimated EPS of $3.27.
Browse guidance and forecast on all stocks.